|
|
|
Volumn 3, Issue 2, 2000, Pages 90-99
|
|
Prevention of breast cancer
a
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARZOXIFENE;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
BEHAVIOR MODIFICATION;
BREAST CANCER;
CANCER RISK;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEEP VEIN THROMBOSIS;
DRUG EFFECT;
DRUG EFFICACY;
ENDOMETRIUM CANCER;
FEMALE;
HIGH RISK POPULATION;
HUMAN;
LIFESTYLE;
LUNG EMBOLISM;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK FACTOR;
STROKE;
THROMBOEMBOLISM;
|
|
EID: 0033928071
PISSN: 10924450
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (82)
|
